Research
Hormonal
GLP-1 agonists are associated with favorable hemoglobin A1C levels and weight loss in type 1 diabetic patients.
GLP-1 agonists may be recommended for type 1 diabetes patients aiming for better glycemic control and weight management.
StrongSupportsmedium confidence
The utilization of glucagon-like peptide-1 (GLP-1) agonists is an object of research with favorable hemoglobin A1C levels and weight loss in type 1 diabetic patients.
Why this rating
The claim is supported by research findings.
Source
Recent clinical and pharmacological advancements of incretin-based therapy and the effects of incretin on physiology
Bhaskar Pal et al. · Journal of Diabetology · 2024
reviewCited 4×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →